VNDA - Vanda Pharmaceuticals Inc

https://www.vandapharma.com

Hold Momentum: Bearish

Recent News

Legend Biotech ( LEGN ) Surges 6.0%: Is This an Indication of Further Gains?

Legend Biotech (LEGN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Downtrend

As of 2025-09-10 (Snapshot)

Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company is headquartered in Washington, the District of Columbia.

52W High

$5.54

52W Low

$3.81

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

0.74

Valuation

Rich

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

92.59

EV/EBITDA (<8 favorable)

12.91

EV/Revenue (<3 favorable)

0.59

P/S (TTM) (<3 favorable)

1.34

P/B (<3 favorable)

0.56

Ownership

Institution‑heavy

Source: Overview

Insiders (1–5% typical)

7.21%

Institutions (25–75% balanced)

78.62%

Shares Outstanding

59,089,000

Float

49,483,000

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

203,467,000

Gross Profit (TTM)

192,069,000

EPS (TTM)

-1.14

Profit Margin (>10% good)

-0.33%

Operating Margin (TTM) (higher better)

-0.73%

ROE (TTM) (>15% strong)

-0.13%

EPS YoY (Quarterly) (>10% good)

-0.96

Revenue YoY (Quarterly) (>8% good)

0.04

Momentum

Bearish momentum

Value

0.0031

0.0120

Trend

Falling

Signal Cross

No cross

As of

Sep. 12, 2025